Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Assay and drug development technologies

• Publication date

  2016-02-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1089/adt.2015.673PMID 26565779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.

  2015cited by this paper
• Facing multi-drug resistant tuberculosis.

  2015cited by this paper
• The WHO 2014 global tuberculosis report--further to go.

  2015influential reference
• Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.

  2015cited by this paper
• In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.

  2015cited by this paper
• Gene mutations in Mycobacterium tuberculosis: multidrug-resistant TB as an emerging global public health crisis.

  2015cited by this paper
• Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques

  2015cited by this paper
• Correlation of Inhibitory Effects of Polymers on Indomethacin Precipitation in Solution and Amorphous Solid Crystallization Based on Molecular Interaction

  2014cited by this paper
• SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development.

  2014cited by this paper
• Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities.

  2014cited by this paper
• Exploring the potential of endophytes from medicinal plants as sources of antimycobacterial compounds

  2014cited by this paper
• Flavones: an important scaffold for medicinal chemistry.

  2014cited by this paper
• Multi-target approach for natural products in inflammation.

  2014cited by this paper
• PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ mice.

  2014cited by this paper
• Bedaquiline for the treatment of resistant tuberculosis: promises and pitfalls.

  2014cited by this paper
• Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients

  2014cited by this paper
• Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations

  2014cited by this paper
• Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis.

  2014cited by this paper
• Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.

  2014cited by this paper
• Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.

  2013cited by this paper
• Challenges in the development of drugs for the treatment of tuberculosis

  2013cited by this paper
• Studying the effect of lipid chain length on the precipitation of a poorly water soluble drug from self‐emulsifying drug delivery system on dispersion into aqueous medium

  2013cited by this paper
• Alkaloids as important scaffolds in therapeutic drugs for the treatments of cancer, tuberculosis, and smoking cessation.

  2013cited by this paper
• Bedaquiline - The first ATP synthase inhibitor against multi drug resistant tuberculosis.

  2013cited by this paper
• Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions.

  2013cited by this paper
• Clinical Benefit of Delamanid (OPC-67683) in the Treatment of Multidrug-Resistant Tuberculosis Patients in China

  2013cited by this paper
• Rising to the challenge: new therapies for tuberculosis.

  2013cited by this paper
• Bactericidal Activity and Mechanism of Action of AZD5847, a Novel Oxazolidinone for Treatment of Tuberculosis

  2013cited by this paper
• Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32

  2013cited by this paper
• Natural products: a continuing source of novel drug leads.

  2013cited by this paper
• In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis

  2013cited by this paper
• Drug-resistant tuberculosis: time for visionary political leadership.

  2013cited by this paper
• Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32.

  2013cited by this paper
• One pot solvent free synthesis and in vitro antitubercular screening of 3-Aracylphthalides against Mycobacterium tuberculosis.

  2013cited by this paper
• Bacterial diterpene synthases: new opportunities for mechanistic enzymology and engineered biosynthesis.

  2012cited by this paper
• Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers.

  2012cited by this paper
• Representations of MDR and XDR-TB in South African newspapers.

  2012cited by this paper
• Inhaled Microparticles Containing Clofazimine Are Efficacious in Treatment of Experimental Tuberculosis in Mice

  2012cited by this paper
• Antimalarial and antitubercular C-glycosylated benz[α]anthraquinones from the marine-derived Streptomyces sp. BCC45596

  2012cited by this paper
• Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis.

  2012cited by this paper
• Natural products as sources of new drugs over the 30 years from 1981 to 2010.

  2012cited by this paper
• Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

  2012cited by this paper
• The role of the β5-α11 loop in the active-site dynamics of acylated penicillin-binding protein A from Mycobacterium tuberculosis.

  2012cited by this paper
• Synthesis and antimycobacterial activity of calpinactam derivatives.

  2012cited by this paper
• Tuberculosis: the drug development pipeline at a glance.

  2012cited by this paper
• Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents.

  2012cited by this paper
• Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

  2012cited by this paper
• Syntheses and biological evaluation of new triazole-spirochromone conjugates as inhibitors of Mycobacterium tuberculosis

  2011cited by this paper
• Constituents in kava extracts potentially involved in hepatotoxicity: a review.

  2011cited by this paper
• Dihydro-β-agarofuran sesquiterpenes isolated from Celastrus vulcanicola as potential anti-Mycobacterium tuberculosis multidrug-resistant agents.

  2011cited by this paper
• Challenges of Antibacterial Discovery

  2011cited by this paper
• The methylerythritol phosphate (MEP) pathway for isoprenoid biosynthesis as a target for the development of new drugs against tuberculosis.

  2011cited by this paper
• Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.

  2011cited by this paper
• Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.

  2011cited by this paper
• The oxazolidinones: past, present, and future

  2011cited by this paper
• Novel quinoline and naphthalene derivatives as potent antimycobacterial agents.

  2010cited by this paper
• Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth.

  2010cited by this paper
• Sesquiterpenes from Oplopanax horridus.

  2010cited by this paper
• anti-Tuberculosis natural products: synthesis and biological evaluation of pyridoacridine alkaloids related to ascididemin

  2010cited by this paper
• Synthesis enables a structural revision of the Mycobacterium tuberculosis-produced diterpene, edaxadiene.

  2010cited by this paper
• Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria.

  2010cited by this paper
• The dark side of curcumin

  2010cited by this paper
• Alkaloids as potential anti-tubercular agents.

  2009cited by this paper
• Efficacy of Artemisia afra phytotherapy in experimental tuberculosis.

  2009cited by this paper
• The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.

  2009cited by this paper
• Edaxadiene: A New Bioactive Diterpene from Mycobacterium tuberculosis

  2009cited by this paper
• Biomimetic transformation and biological activities of Globiferin, a terpenoid benzoquinone from Cordia globifera.

  2009cited by this paper
• Characterization and Inhibition of a Class II Diterpene Cyclase from Mycobacterium tuberculosis

  2009cited by this paper
• Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.

  2008cited by this paper
• Comparative cytotoxic and anti-tuberculosis activity of Aplysina caissara marine sponge crude extracts.

  2008cited by this paper
• Synthesis and in vitro biological evaluation of ring B abeo-sterols as novel inhibitors of Mycobacterium tuberculosis.

  2008cited by this paper
• Modification of the side chain of micromolide, an anti-tuberculosis natural product.

  2008cited by this paper
• Microwave-assisted synthesis and antimicrobial activities of flavonoid derivatives.

  2008cited by this paper
• A New Dihydroagarofuranoid Sesquiterpene and Antituberculosis Constituents from the Root of Microtropis japonica

  2008cited by this paper
• Activity against drug resistant‐tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases

  2008cited by this paper
• A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial.

  2008cited by this paper
• Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent.

  2008cited by this paper
• QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using genetic function approximation (GFA) method.

  2007cited by this paper
• Novel ring B abeo-sterols as growth inhibitors of Mycobacterium tuberculosis isolated from a Caribbean Sea sponge, Svenzea zeai

  2007cited by this paper
• Drugs for bad bugs: confronting the challenges of antibacterial discovery

  2007cited by this paper
• Bioactive compounds from Bauhinia purpurea possessing antimalarial, antimycobacterial, antifungal, anti-inflammatory, and cytotoxic activities.

  2007cited by this paper
• A New Dihydroagarofuranoid Sesquiterpene from Microtropis fokienensis with Antituberculosis Activity

  2007cited by this paper
• Antiviral and antituberculous activity of Helichrysum melanacme constituents.

  2006cited by this paper
• Antimycobacterial flavonoids from Derris indica.

  2006cited by this paper
• Preclinical Testing of the Nitroimidazopyran PA-824 for Activity against Mycobacterium tuberculosis in a Series of In Vitro and In Vivo Models

  2005cited by this paper
• 3-Nitropropionic acid (3-NPA), a potent antimycobacterial agent from endophytic fungi: is 3-NPA in some plants produced by endophytes?

  2005cited by this paper
• Recent advances in new structural classes of anti-tuberculosis agents.

  2005cited by this paper
• Quinones as antimycobacterial agents.

  2004cited by this paper
• Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy.

  2004cited by this paper
• Acetylene-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.

  2003cited by this paper
• Chalcones and flavonoids as anti-tuberculosis agents.

  2002cited by this paper
• Biflavonoids as novel antituberculosis agents.

  2001cited by this paper
• Pure compound libraries; a new perspective for natural product based drug discovery.

  2001cited by this paper
• A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

  2000cited by this paper
• Promises and pitfalls of the

  1997cited by this paper
• In Vitro Activities of Fourteen Antimicrobial Agents Against Drug Susceptible and Resistant Clinical Isolates of Mycobacterium tuberculosis and Comparative Intracellular Activities Against the Virulent H37Rv Strain in Human Macrophages

  1996cited by this paper

• Total Synthesis of iso-Gladiolin Methyl Ester (Lagriene Methyl Ester) via Catalytic Asymmetric C-C Coupling of Alcohols.

  2026cites this paper
• Computational analysis of Phanera sirindhorniae flavonoids as potential inhibitors of Mycobacterium tuberculosis DNA gyrase ATPase

  2025cites this paper
• Unlocking potent anti-tuberculosis natural products through structure–activity relationship analysis

  2025cites this paper
• Determining the Antimycobacterial Action of Rottlerin Against Mycobacterium Species and Toxicity, Antioxidant Properties, and Therapeutic Target Affinity of Rottlerin

  2025cites this paper
• INSIGHTS INTO THERAPEUTIC LIQUID MIXTURES AND FORMULATIONS TOWARDS TUBERCULOSIS THERAPY.

  2023cites this paper
• Isoflavonoid and Furanochromone Natural Products as Potential DNA Gyrase Inhibitors: Computational, Spectral, and Antimycobacterial Studies

  2023cites this paper
• Investigation of Copaifera genus as a new source of antimycobaterial agents

  2020cites this paper
• Evaluation of peptide-rich root extracts of Calliandria portoriscensis (Jacq.) Benth (Mimosaceae) for in vitro antimicrobial activity and brine shrimp lethality

  2020cites this paper
• Design, synthesis, in silico studies, and evaluation of novel chalcones and their pyrazoline derivatives for antibacterial and antitubercular activities

  2020cites this paper
• Lead molecules from natural products: Insight into tubercular targets

  2020cites this paper
• Marine Natural Products and Drug Resistance in Latent Tuberculosis

  2019cites this paper
• PENGARUH SUPPLEMENTASI PROBIOTIK DAN SELENIUM TERHADAP RESPON IMUN NLR (NEUTROPHIL LYMPHOCYTE COUNT RATIO) , HAEMOGLOBIN DAN ALBUMIN PADA TIKUS WISTAR YANG DIINDUKSI MYCOBAKTERIUM TUBERCULOSIS

  2019cites this paper
• Antimycobacterial, antimicrobial, antioxidant activities and in silico PASS investigations of root fractions and extract of Cordia dichotoma Forst

  2019cites this paper
• Antibacterial Activity and Mechanism of Action of Aspidinol Against Multi-Drug-Resistant Methicillin-Resistant Staphylococcus aureus

  2018cites this paper
• New Isoflavonoids from the extract of Rhynchosia precatoria (Humb. & Bonpl. ex Willd.) DC. and their antimycobacterial activity.

  2017cites this paper
• Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products

  2017cites this paper
• Collaborative drug discovery for More Medicines for Tuberculosis (MM4TB).

  2017cites this paper
• Anti-tubercular Clofazimine Analogs with Improved Physicochemical Properties

  2016cites this paper